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Summary 
 
Neuropepetide Y (NPY) is best known for its powerful stimulation of food intake and its effects 
on reducing energy expenditure. However, the pathways involved and the regulatory 
mechanisms behind this are not well understood. Here we demonstrate that NPY derived 
from the arcuate nucleus (Arc) is critical for the control of sympathetic outflow and brown 
adipose tissue (BAT) function. Mechanistically, a key change induced by Arc NPY signaling is 
a marked Y1 receptor-mediated reduction in tyrosine hydroxylase (TH) expression in the 
hypothalamic paraventricular nucleus (PVN), which is also associated with a reduction in TH 
expression in the locus coeruleus (LC) and other regions in the brainstem. Consistent with 
this, Arc NPY signaling decreased sympathetically innervated BAT thermogenesis, involving 
the downregulation of uncoupling protein 1 (UCP1) expression in BAT. Taken together, these 
data reveal a powerful Arc-NPY-regulated neuronal circuit that controls BAT thermogenesis 
and sympathetic output via TH neurons. 
Introduction 
 
Obesity occurs when there is a significant imbalance between energy intake and energy 
expenditure (Rosen and Spiegelman, 2006). While energy intake is almost entirely 
determined by food intake, energy expenditure is composed of several components, including 
basal metabolism, physical activity, and thermogenesis (Rosen and Spiegelman, 2006). 
Reduced adaptive thermogenesis has been reported to be responsible for reduced energy 
expenditure during energy deficit, as in weight loss programs (Major et al., 2007). In recent 
years, more focused research into the regulation of thermogenesis, particularly brown 
adipose tissue (BAT) thermogenesis, has indicated that BAT is under tight control by the 
central nervous system (CNS) (Whittle et al., 2011), of which the hypothalamus, and in 
particular the arcuate nucleus (Arc), has attracted special attention. 
 The Arc contains two major populations of neurons that are known to regulate energy 
balance: orexigenic neuropeptide Y (NPY)/agouti-related peptide (AGRP)-containing neurons, 
and anorexigenic proopiomelanocortin (POMC)/cocaine and amphetamine-regulated 
transcript (CART)-containing neurons (Lin et al., 2004) (Hahn et al., 1998). Activation of 
NPY/AGRP neurons leads to the release of NPY and AGRP, which strongly stimulate 
appetite and, when chronically elevated, lead to the development of obesity (Ellacott and 
Cone, 2004). This occurs via signaling of NPY on Y receptors, notably Y1 and Y5 receptors 
(Nguyen et al., 2012), as well as via the ability of AGRP to antagonize melanocortin 3/4 
(MC3/4) receptors (Ellacott and Cone, 2004). Consistent with an important role of NPY in the 
regulation of energy homeostasis, chronic intracerebroventricular (i.c.v.) or hypothalamus-
specific administration of NPY to rodents leads to hyperphagia, accompanied by accelerated 
body weight gain, hyperleptinemia, hypercorticosteronemia, hyperinsulinemia, and increased 
adiposity (Sainsbury et al., 1997a; Zarjevski et al., 1993). More importantly, all of these 
neuroendocrine and metabolic effects of central NPY administration, notably increased 
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adiposity, persist even when NPY-induced hyperphagia is prevented by pair feeding 
(Sainsbury et al., 1997b; Zarjevski et al., 1993). This indicates that hyperphagia is not the 
only mechanism by which central NPY increases adiposity and demonstrates that 
hypothalamic NPY must also alter other processes, such as energy expenditure, that 
contribute to the increased adiposity. In addition, elevated NPY-ergic tone and decreased 
adaptive thermogenesis during energy restriction and weight loss intervention suggest a 
possible relationship between Arc NPY signaling and adaptive thermogenesis (Major et al., 
2007). 
 Despite the number of studies documenting the effects of central NPY administration 
on energy homeostasis, the molecular mechanisms underlying these effects, including central 
and peripheral signaling pathways, are yet to be elucidated. One mechanism by which Arc 
NPY may decrease energy expenditure is through interaction with the sympathetic nervous 
system (SNS). Interestingly, increased hypothalamic NPY expression has been shown in 
animal models of obesity (Lin et al., 2000), and elevated circulating NPY levels have been 
found in obese women (Baranowska et al., 2005; Milewicz et al., 2000). On the other hand, 
many obesity syndromes are also associated with low sympathetic activity (Bray and York, 
1998). While the relationship between Arc NPY and the SNS has been postulated, with 
demonstrations that hypothalamic NPY administration reduces sympathetic firing rate 
(Lundberg et al., 1989) or reduces sympathetically mediated processes such as BAT 
thermogenesis (Egawa et al., 1991), there is little known about the pathways involved or the 
underlying mechanism that controls it. 
 BAT has gained interest as a possible target for the normal control and treatment of 
obesity in adult humans via modulation of cold-induced and adaptive thermogenesis 
(Stephens et al., 2011). Moreover, there is an inverse correlation between the amount of BAT 
and body mass index in humans, with obese individuals having significantly less BAT than 
lean individuals (Virtanen et al., 2009). Considering the critical role that Arc NPY plays in the 
control of energy homeostasis, together with the fact that pair-fed animals with elevated Arc 
NPY levels still develop obesity (Sainsbury et al., 1997b; Zarjevski et al., 1993), we aimed to 
determine the brain circuits via which Arc NPY controls energy expenditure and SNS activity 
and subsequently modulates BAT activity. To this end, we utilized mouse models in which 
NPY is only produced in the Arc ectopically as well as more specifically only in Arc NPY 
neurons while it is absent everywhere else. This was achieved by adeno-associated virus 
(AAV)-mediated neuronal expression of NPY specifically in the Arc of NPY knockout (NPY−/−) 
mice as well as AAV-FLEX-NPY-mediated Arc-NPY-specific expression in NPYCre knockin 
mice. NPY−/− mice were used because they enabled us to specifically dissect the role of Arc 
NPY independently of effects of other central or peripheral NPY pathways. Knowledge of the 
central regulation of BAT functionality gained from these experiments using techniques that 
are impossible in humans provides new information relevant to the control of energy 
homeostasis in humans. 
 
Results 
 
Long-Term High-Fat Feeding Induces Elevation of Arc NPY mRNA Expression 
Under normal conditions, Arc NPY expression is controlled by peripheral factors such as 
leptin and insulin and satiety factors like peptide YY (PYY), all of which reduce Arc NPY 
messenger RNA (mRNA) levels thus signaling a positive energy balance (Batterham et al., 
2002; Elmquist et al., 1998; Marks et al., 1990). On the other hand, fasting and ghrelin action 
promote the opposite: an upregulation of Arc NPY mRNA levels, which signal negative 
energy balance and trigger an increase in appetite and a reduction in energy expenditure 
(Kamegai et al., 2000; Sainsbury and Zhang, 2010). This was evident in the Arc of wild-type 
(WT) mice after a 24 hr fasting period, which showed significantly elevated NPY mRNA 
expression (Figure 1Aa), compared to that in nonfasted chow-fed mice (Figure 1Ac). 
Paradoxically, these principles no longer apply under conditions of long-term overfeeding as 
seen in mice fed a high-fat diet for 20 weeks, in which Arc NPY mRNA expression was also 
significantly increased compared to chow-fed controls (Figures 1Ab and 1Ac). These results 
suggest that the dysregulated Arc NPY levels present in the high-fat-fed animals mimic an 
energy-deficit state that most likely exacerbates the already established obesity due to a 
further increase in food intake and reduction in energy expenditure, highlighting the critical 
importance of the Arc NPY system under obese conditions. 
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Mouse Models for Specific Expression of NPY Only in the Arc 
In order to recapitulate the changes in energy expenditure under conditions of energy-deficit 
or long-term high caloric intake, and to specifically characterize the neuronal pathways 
involved in Arc NPY-induced reduction in energy expenditure and thermogenesis, we 
generated mouse models in which NPY is either overproduced in WT mice specifically in the 
Arc or selectively reintroduced into the Arc of otherwise NPY-deficient mice. We injected a 
recombinant adeno-associated virus that expresses NPY under a neuron-specific promoter 
(AAV-NPY) into the Arc of 11-week-old WT or germline NPY−/− mice (hereafter referred to as 
WT+NPY or ArcNPY, respectively) using an empty AAV (AAV-empty) as a control (hereafter 
referred to as WT+empty or NPY−/−+empty, respectively). Viral delivery was targeted to just 
next to the Arc to avoid destruction of the nucleus, but close enough to allow diffusion of the 
virus into the Arc (right side of Figure 1Ba and higher-magnification of the boxed area in 
Figure 1Bb). The needle track shown in Figure 1Bb confirmed the precise Arc-targeted 
injection. Immunohistochemistry revealed a unilateral increase in NPY peptide expression in 
the Arc of NPY−/− mice (Figure 1Bb). 
 In addition to these models, we also utilized our NPYCre knockin line, which allows 
NPY to be specifically expressed only in NPY neurons in the Arc. In this model, the Cre-
recombinase gene is under the control of the endogenous NPY promoter. When injected with 
an AAV-NPY-FLEX vector, this guarantees that Cre-recombinase is only active in NPY 
neurons and that inversion of the inactive NPY gene in the AAV-NPY-FLEX vector to the 
active form only occurs in these NPY-expressing neurons. Successful activation of NPY 
expression in the Arc through this method is shown in Figure 1Bc, with NPY neurons 
indicated by the coexpression of mCherry (red) and NPY derived from the viral vector 
visualized by immunohistochemistry (green). 
overproducing NPY in the Arc, suggesting that extra-Arc sources
of NPY are also critical for increasing body weight. Importantly,
there was no significant difference between the ArcNPY and
the Arc-FLEX-NPY groups with regard to body weight and other
parameters described below, suggesting the effects of NPY in
the ArcNPY model are mediated by NPY neurons. However,
since overexpression of NPY in WT, Y1!/!, Y2!/!, and Y1lox/lox
mice, all of which were used in this study, was not possible
with the AAV-FLEX-NPY virus, all comparisons below are shown
between WT+NPY or ArcNPY and the respective AAV-empty
controls.
Arc Only NPY Signaling Directly Decreases Whole-Body
Energy Expenditure
In order to investigate the direct consequences of Arc NPY
signaling on energy expenditure while avoiding potential
secondary effects that could be caused by themarked increases
in body weight that occur ov r a long r period of time (Fig-
ure S1A), we a alyzedWT+NPY and ArcNPYmice ithin the first
3 weeks after viral delivery. Mice were monitored for body
weight, energy expenditure, and food intake. At day 8 after injec-
tion, NPY!/!+emptymice consumed significantly less food than
did theWT+ mpty mice (Figure 1C). Importantly, however, food
intak was increase overWT+empty values in theWT+NPY and
ArcNPY mice, with ArcNPY mice also consuming significantly
more than their corresponding controls, confirming the function-
ality of the virally delivered NPY (Figure 1C). Despite this increase
in 24 hr food intake, body weight (Figure S1B) and whole-body
fat mass (Figure S1C) were not significantly different from those
of mice in the WT+em t or NPY!/!+empty groups.
Strikingly, despite similar body weight and adiposity, oxygen
consumption (Figure 2A) and carbon dioxide (CO2) production
(Figure S1D) in WT+NPY and ArcNPY mice were reduced
compared to the corresponding control values (Figure 2A).
These changes were associated with a significant reduction in
energy expenditure in both genotypes (Figure 2B), indicating
a direct inhibitory action caused by Arc NPY signaling. These
findings strongly suggest that Arc NPY reduce energy
Figure 1. Arc NPY Expression under Various Conditions
(A) 35S-labeled in situ hybridization shows NPY mRNA expression in the Arc of WT mice fasted for 24 hr (a), (b) after 20 weeks of high-fat diet (HFD) (b), and
nonfasted chow-fed WT mice (c). The scale bar represents 60 mm.
(B) Shown in (a) is a photomicrograph of coronal brain section showing immunostaining of NPY after unilateral injection of AAV-NPY virus into the Arc of NPY!/!
mice (on the right side). Shown in (b) is a higher-magnification of boxed area in (a) showing the needle track just outside the Arc (the scale bar represents 40 mm).
Shown in (c) is a representative photomicrograph of coronal brain section showing successful NPY restoration only into NPY neurons of the Arc of NPYCre
knockin mice with an AAV-FLEX-NPY vector. The reintroduced NPY is detected with immunohistochemistry with an antibody coupled to a green fluorescence
protein seen as yellow due to the overlap of colocalized red fluorescence of the mCherry gene only expressed in NPY-expressing neurons. The scale bar
represents 40 mm. Inset is a higher magnification of the boxed area; the scale bar represents 25 mm. 3V, the third cerebral ventricle; Arc, arcuate nucleus.
(C) Daily food intakemeasured 1week after AAV virus injection. Data aremeans ± SEM. n = 8–10mice per group. *p < 0.05 versus genotype-matched AAV-empty
or for the comparisons indicated by horizontal bar.
See also Figure S1.
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 Consistent with previous results (Lin et al., 2006), vector-mediated NPY expression 
was seen as early as day 3 after injection and was stable for at least 6 months, at which time 
the expression was still confined to the Arc (data not shown). In keeping with our histological 
confirmation of successful reintroduction or overexpression of NPY in the Arc, body weight of 
our models was markedly increased over the 8 weeks after the injection period, as compared 
to their corresponding controls (Figure S1A available online). Interestingly, however, body 
weight gain in the Arc reintroduced models on an otherwise NPY-deficient background was 
significantly less than that of WT mice overproducing NPY in the Arc, suggesting that extra-
Arc sources of NPY are also critical for increasing body weight. Importantly, there was no 
significant difference between the ArcNPY and the Arc-FLEX-NPY groups with regard to body 
weight and other parameters described below, suggesting the effects of NPY in the ArcNPY 
model are mediated by NPY neurons. However, since overexpression of NPY in WT, Y1−/−, 
Y2−/−, and Y1lox/lox mice, all of which were used in this study, was not possible with the AAV-
FLEX-NPY virus, all comparisons below are shown between WT+NPY or ArcNPY and the 
respective AAV-empty controls. 
 
Arc Only NPY Signaling Directly Decreases Whole-Body Energy Expenditure 
In order to investigate the direct consequences of Arc NPY signaling on energy expenditure 
while avoiding potential secondary effects that could be caused by the marked increases in 
body weight that occur over a longer period of time (Figure S1A), we analyzed WT+NPY and 
ArcNPY mice within the first 3 weeks after viral delivery. Mice were monitored for body 
weight, energy expenditure, and food intake. At day 8 after injection, NPY−/−+empty mice 
consumed significantly less food than did the WT+empty mice ( Figure 1C). Importantly, 
however, food intake was increased over WT+empty values in the WT+NPY and ArcNPY 
mice, with ArcNPY mice also consuming significantly more than their corresponding controls, 
confirming the functionality of the virally delivered NPY ( Figure 1C). Despite this increase in 
24 hr food intake, body weight (Figure S1B) and whole-body fat mass (Figure S1C) were not 
significantly different from those of mice in the WT+empty or NPY−/−+empty groups. 
 Strikingly, despite similar body weight and adiposity, oxygen consumption (Figure 2A) 
and carbon dioxide (CO2) production (Figure S1D) in WT+NPY and ArcNPY mice were 
reduced compared to the corresponding control values ( Figure 2A). These changes were 
associated with a significant reduction in energy expenditure in both genotypes (Figure 2B), 
indicating a direct inhibitory action caused by Arc NPY signaling. These findings strongly 
suggest that Arc NPY reduces energy expenditure before significant changes in fat mass and 
body weight occur, implying that the direct inhibitory effect observed is not simply a 
consequence of increased body weight or adiposity. 
 
	  	  
expenditure before significant changes in fat mass and body
weight occur, implying that the direct inhibitory effect observed
is not simply a consequence of increased body weight or
adiposity.
While Arc NPY signaling had significant short-term effects on
oxygen consumption and energy expenditure, there was no
major effect of Arc NPY signaling on physical activity in WT or
NPY!/! mice (Figure S1E). However, respiratory exchange ratio
(RER), an index of oxidative fuel source in NPY!/!+empty mice,
was significantly lower than that in WT+empty mice, with
ArcNPY mice showing a trend to reverse this effect on RER
(p = 0.1), which is particularly evident during the dark phase
(Figure S1F).
Taken together, these observations demonstrate that Arc
NPY signaling directly inhibits energy expenditure indepen-
dently of changes in body weight without major influences on
physical activity and show that Arc NPY might have a role in
fuel source selection, which could potentially impact on energy
expenditure. These differences in energy expenditure also point
to the possibility that the Arc-NPY-induced reduction in energy
expenditure may be associated with modulation of body
temperature. However, rectal temperatures of WT+NPY and
ArcNPY mice in the short-term experiment were not different
from those of genotype-matched control mice (data not
shown). More-sensitive measures of temperature were thus
conducted.
Arc Only NPY Signaling Decreases BAT Temperature
Since levels of NPY are strongly influenced by stress, we
utilized a noninvasive high-sensitivity infrared imaging camera
to monitor the temperature of interscapular BAT (TBAT), as
indicated by the temperature of the overlaying skin in com-
parison with body temperature represented by lumbar skin
temperature of freely moving animals (TBack). These experiments
were done 10 days after Arc NPY administration. There was
no difference in BAT temperature between WT+empty and
NPY!/!+empty mice (Figures 3A and 3B). However, WT+NPY
mice displayed a significant reduction in BAT temperature
compared to WT+empty control mice (Figures 3A and 3B).
Importantly, NPY reintroduction only into the Arc of NPY!/!
mice also led to a significant reduction in BAT temperature
relative to that of NPY!/!+empty mice (Figures 3A and 3B),
demonstrating that NPY signaling in this nucleus alone is able
to influence BAT thermogenesis. Lumbar temperature reflecting
overall body temperature showed a significant reduction in WT
mice upon Arc NPY overproduction but did not reach signifi-
cance in the NPY reintroduction models (Figure 3B), suggesting
that other NPY sources might contribute to this body tempera-
ture control.
Arc NPY Signaling Controls POMC and GAD65 but Not
AGRP Expression
Having demonstrated the clear link between Arc NPY and energy
expenditure and BAT thermogenesis, we next attempted to
dissect the neuronal pathways and circuits initiated by Arc-
specific NPY signaling. First, we assessed how increased Arc
NPY signaling affects the expression levels of other known regu-
lators of energy balance such as POMC and AGRP (Mountjoy,
2010; Ollmann et al., 1997; Tolle and Low, 2008) using in situ
hybridization. Unilateral injection of the respective AAV vectors
was chosen because it allowed us to use the contralateral side
as an internal control. As an additional control, different sets of
WT and knockout animals were unilaterally injected with an
empty vector (AAV-empty). NPY!/!+empty mice did not show
any significant difference from WT+empty mice with respect to
Arc mRNA expression levels of POMC (Figure 4A). However,
compared to the levels in genotype-matched AAV-empty-in-
jected controls, overexpression of NPY targeted to the Arc led
to marked reductions in POMC mRNA expression in WT+NPY
mice (64.5% ± 5.2% versus 100.0% ± 3.2% in WT+empty
Figure 2. Effects of Arc NPY Signaling on Oxygen Consumption and Energy Expenditure in WT and NPY–/– Mice
Oxygen consumption (A) and energy expenditure (B) measured by indirect calorimetry 1 week after injection with AAV-empty or AAV-NPY vectors into the Arc of
13-week-old WT and NPY!/!mice, respectively. Open and black horizontal bars indicate light and dark phases, respectively. Average oxygen consumption and
energy expenditure over total 24 hr period were also calculated and are shown as bar graphs. Data are means ± SEM. n = 5–8 mice per group. *p < 0.05 and
**p < 0.01 versus genotype-matched AAV-empty controls or for the comparison indicated by horizontal bar. See also Figure S1.
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 While Arc NPY signaling had significant short-term effects on oxygen consumption 
and energy expenditure, there was no major effect of Arc NPY signaling on physical activity in 
WT or NPY−/− mice (Figure S1E). However, respiratory exchange ratio (RER), an index of 
oxidative fuel source in NPY−/−+empty mice, was significantly lower than that in WT+empty 
mice, with ArcNPY mice showing a trend to reverse this effect on RER (p = 0.1), which is 
particularly evident during the dark phase ( Figure S1F). 
 Taken together, these observations demonstrate that Arc NPY signaling directly 
inhibits energy expenditure independently of changes in body weight without major influences 
on physical activity and show that Arc NPY might have a role in fuel source selection, which 
could potentially impact on energy expenditure. These differences in energy expenditure also 
point to the possibility that the Arc-NPY-induced reduction in energy expenditure may be 
associated with modulation of body temperature. However, rectal temperatures of WT+NPY 
and ArcNPY mice in the short-term experiment were not different from those of genotype-
matched control mice (data not shown). More-sensitive measures of temperature were thus 
conducted. 
 
Arc Only NPY Signaling Decreases BAT Temperature 
Since levels of NPY are strongly influenced by stress, we utilized a noninvasive high-
sensitivity infrared imaging camera to monitor the temperature of interscapular BAT (TBAT), as 
indicated by the temperature of the overlaying skin in comparison with body temperature 
represented by lumbar skin temperature of freely moving animals (TBack). These experiments 
were done 10 days after Arc NPY administration. There was no difference in BAT 
temperature between WT+empty and NPY−/−+empty mice ( Figures 3A and 3B). However, 
WT+NPY mice displayed a significant reduction in BAT temperature compared to WT+empty 
control mice ( Figures 3A and 3B). Importantly, NPY reintroduction only into the Arc of NPY−/− 
mice also led to a significant reduction in BAT temperature relative to that of NPY−/−+empty 
mice ( Figures 3A and 3B), demonstrating that NPY signaling in this nucleus alone is able to 
influence BAT thermogenesis. Lumbar temperature reflecting overall body temperature 
showed a significant reduction in WT mice upon Arc NPY overproduction but did not reach 
significance in the NPY reintroduction models (Figure 3B), suggesting that other NPY sources 
might contribute to this body temperature control. 
 
Arc NPY Signaling Controls POMC and GAD65 but Not AGRP Expression 
Having demonstrated the clear link between Arc NPY and energy expenditure and BAT 
thermogenesis, we next attempted to dissect the neuronal pathways and circuits initiated by 
Arc-specific NPY signaling. First, we assessed how increased Arc NPY signaling affects the 
expression levels of other known regulators of energy balance such as POMC and AGRP 
(Mountjoy, 2010; Ollmann et al., 1997; Tolle and Low, 2008) using in situ hybridization. 
Unilateral injection of the respective AAV vectors was chosen because it allowed us to use 
the contralateral side as an internal control. As an additional control, different sets of WT and 
knockout animals were unilaterally injected with an empty vector (AAV-empty). NPY−/−+empty 
mice did not show any significant difference from WT+empty mice with respect to Arc mRNA 
expression levels of POMC ( Figure 4A). However, compared to the levels in genotype-
matched AAV-empty-injected controls, overexpression of NPY targeted to the Arc led to 
marked reductions in POMC mRNA expression in WT+NPY mice (64.5% ± 5.2% versus 
100.0% ± 3.2% in WT+empty controls, means ± SEM of five mice per group, p < 0.01) and in 
ArcNPY mice (77.4% ± 8.7% versus 100.4% ± 6.0% in NPY−/−+empty mice, means ± SEM of 
five mice per group, p < 0.01) ( Figure 4A). 
           It has been suggested that NPY in the hypothalamus may modulate gamma 
aminobutyric acid (GABA)-ergic activity, and through this pathway indirectly influence POMC 
expression (Cowley et al., 2001; Horvath et al., 1992; Jegou et al., 1993; Vergoni and 
Bertolini, 2000). We thus investigated the effect of Arc NPY signaling on mRNA expression of 
glutamic acid decarboxylase 65 (GAD65), a key enzyme in the synthesis of GABA. Baseline 
levels of GAD65 mRNA were not significantly different between WT and NPY−/− mice 
(Figure 4B). However, overproduction or reintroduction of Arc-specific NPY expression 
resulted in significant elevations in Arc GAD65 mRNA levels in both WT and NPY−/− mice 
(Figure 4B). This suggests that Arc NPY may enhance GABA production by increasing Arc 
GAD65 production, which may subsequently contribute to the reduction of POMC mRNA 
expression. Interestingly, the mRNA expression levels of AGRP, which is coexpressed with 
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endogenous NPY in some Arc neurons and whose expression levels were no different 
between WT and NPY−/− mice at baseline, did not change upon overproduction or re-
introduction of NPY in WT or NPY−/− mice, respectively (Figure 4C). Thus, Arc NPY seems 
not to be involved in the feedback control of AGRP, suggesting that NPY and AGRP can 
influence energy homeostasis independently. 
	  
	  	  	  
Arc NPY Controls Tyrosine Hydroxylase Expression in the PVN 
In order to determine other downstream targets of Arc NPY signaling, we next aimed to 
identify the chemical identity of neurons activated by Arc-specific NPY. Comparing the 
expression of mRNA of various neurotransmitters in the PVN of lean versus high-fat-diet-fed 
obese animals, which are known to have elevated Arc NPY levels (Figures 1Aa and 1Ac), we 
identified tyrosine hydroxylase (TH), the rate-limiting enzyme in the synthesis of 
catecholamines, as a major candidate on account of its significant downregulation in 
expression in response to a high-fat diet (Figure 4D). To confirm these PVN TH neurons as 
targets for Arc NPY signaling, we used our AAV-NPY expression system and overexpressed 
or reintroduced NPY unilaterally into the Arc of WT and NPY−/− mice. As shown in Figure 4E 
and quantified in Figure 4F, in both genotypes the elevated expression of NPY in the Arc 
caused a significant decrease in TH mRNA expression in the PVN only on the injected side 
(at right in the figure), but not on the contralateral noninjected control side (left) or under 
conditions of empty virus injection. Importantly, another prominent nucleus of TH expression, 
the locus coeruleus (LC), also showed significant downregulation of TH mRNA only on the 
injected side (at right on the figure) and not on the contralateral noninjected control side at left 
or in empty virus-injected controls (Figures 4E and 4F). Interestingly, the downregulation of 
TH mRNA in the two nuclei investigated (PVN and LC) was not significantly different between 
Arc-specific NPY-overexpressing WT and NPY−/− mice (Figure 4F), suggesting that extra-Arc 
NPY may not play a critical role in the regulation of TH mRNA expression in the PVN or LC. 
Consistent with the decreased mRNA level of TH in the PVN and LC of Arc-specific NPY 
controls, means ± SEM of five mice per group, p < 0.01) and in
ArcNPYmice (77.4% ± 8.7% versus 100.4% ± 6.0% in NPY!/!+
empty mice, means ± SEM of five mice per group, p < 0.01)
(Figure 4A).
It has been suggested that NPY in the hypothalamus may
modulate gamma aminobutyric acid (GABA)-ergic activi y, and
through this pat way indirectly influence POMC expression
(Cowley et al., 2001; Horvath et al., 1992; Jegou et al., 1993; Ver-
goni and Bertolini, 2000). We thus investigated the effect of Arc
NPY signaling on mRNA expression of glutamic acid decarbox-
ylase 65 (GAD65), a key enzyme in the synthesis of GABA. Base-
line levels of GAD65 mRNA were not significantly different
between WT and NPY!/! mice (Figure 4B). However, overpro-
duction or reintroduction of Arc-specific NPY expression re-
sulted in significant elevations in Arc GAD65 mRNA levels in
both WT and NPY!/! mice (Figure 4B). This suggests that Arc
NPY may enhance GABA production by increasing Arc G D65
production, which may subsequently contribute to the reduction
of POMCmRNA expression. Interestingly, the mRNA expression
levels of AGRP, which is coexpressed with end genous NPY in
some Arc neurons and whose expression levels were no
different between WT and NPY!/! mice at baseline, did not
change upon overproduction or re-introduction of NPY in WT
or NPY!/! mice, respectively (Figure 4C). Thus, Arc NPY seems
not to be involved in the feedback control of AGRP, suggesting
that NPY and AGRP can influence energy homeostasis
independently.
Figure 3. Effect of Arc NPY Signaling on
BAT Thermogenesis
(A) Color-coded infrared images visualizing BAT
temperatures (rectangular shape, Ar1) and body
temperatures (oval shape, El1) of WT and NPY!/!
mice injected with either AAV-empty or AAV-NPY
into the Arc. Automatically extracted hottest/
coldest pixels and average temperature of area of
interest are displayed at the top left hand corner of
the images. Representative images of 8–10 mice
per group.
(B) Average maximum temperature of BAT (TBAT)
and average maximum temperature of lumbar
back (Tback) of WT and NPY
!/! mice injected with
either AAV-empty or AAV-NPY measured at week
2 after Arc injection. Data are means ± SEM. n = 8–
10 mice per group. *p < 0.05 versus genotype-
matched AAV-empty.
Arc NPY Controls Tyrosine
Hydroxylase Expression in the PVN
In order to determine other downstream
targets of Arc NPY signaling, we next
aimed to identify the chemical identity of
neurons activated by Arc-specific NPY.
Comparing the expression of mRNA
of various neurotransmitters in the PVN
of lean versus high-fat-diet-fed obese
animals, which are known to have
elevated Arc NPY levels (Figures 1Aa
and 1Ac), we identified tyrosine hydroxy-
lase (TH), the rate-limiting enzyme in the
synthesis of catecholamines, as a major candidate on account
of its significant downregulation in expression in response to
a high-fat diet (Figure 4D). To confirm these PVN TH neurons
as targets for Arc NPY signaling, we used our AAV-NPY expres-
sion system and overexpressed or reintroduced NPY unilaterally
into the Arc of WT nd NPY!/!mice. As shown in Figure 4E and
quantified in Figure 4F, in both genotypes the elevated expres-
sion of NPY in the Arc caused a significant decrease in TH
mRNA expression in the PVN only on the injected side (at right
in the figure), but not on the contralateral noninjected control
side (left) or under conditions of empty virus injection. Impor-
tantly, another prominent nucleus of TH expression, the locus
coeruleus (LC), also showed significant downregulation of TH
mRNA only on the injected side (at right on the figure) and not
on the contralateral noninjected control side at left or in empty
virus-injected controls (Figures 4E and 4F). Interestingly, the
downregulation of TH mRNA in the two nuclei investigated
(PVN and LC) was not significantly differ nt between Arc-
specific NPY-overexpressing WT and NPY!/! mice (Figure 4F),
suggestin that extra-Arc NPY may not play a critical role in
the regulation of TH mRNA expression in the PVN or LC. Consis-
tent with the decreased mRNA level of TH in the PVN and LC of
Arc-specific NPY overexpressing mice, decreased TH protein
expression was also identified in these two nuclei by immunohis-
tochemistry (Figures 5A and 5B). In fact, in the PVN and LC of
ArcNPYmice, there were 61 ± 9 and 82 ± 8 TH-positive neurons,
respectively, in the injected side (at right in Figures 5A and 5B)
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controls, means ± SEM of five mice per group, p < 0.01) and in
ArcNPYmice (77.4% ± 8.7% versus 100.4% ± 6.0% in NPY!/!+
empty mice, means ± SEM of five mice per group, p < 0.01)
(Figure 4A).
It has been suggested that NPY in the hypothalamus may
mo ulate gamma aminobutyric acid (GABA)-erg c activit , and
through this pathway indirectly influence POMC expression
(Cowley et al., 2001; Horvath et al., 1992; J gou et al., 1993; Ver-
goni and Bertolini, 2000). We thus investigated the effect of Arc
NPY signaling on mRNA expression of glutamic acid decarbox-
ylase 65 (GAD65), a key nzym i the synthesis of GABA. Base-
line levels of GAD65 mRNA w re n t significa tly different
between WT and NPY!/! mice (Figure 4B). However, overpro-
duction or reintroduction of Arc-specific NPY expression re-
sulted in significant elevations in Arc GAD65 mRNA levels in
both WT and NPY!/! mice (Figure 4B). This suggests that Arc
NPY may enhance GABA oduction by increasing Arc GAD65
production, which m y subsequ ntly contribute to the reduction
of POMCmRNA expression. Interestingly, the mRNA expr ssion
levels of AGRP, which is coexpressed with endogenous NPY in
some Arc neurons and whose expression levels were no
different between WT and NPY!/! mice at baseline, did not
change upon overproduction or re-introduction of NPY in WT
or NPY!/! mice, respectively (Figure 4C). Thus, Arc NPY seems
not to be involved in the feedback control of AGRP, suggesting
that NPY and AGRP can influence energy homeostasis
independently.
Figure 3. Effect of Arc NPY Signaling on
BAT Thermogenesis
(A) Color-coded infrared images visualizing BAT
temperatures (rectangular shape, Ar1) and body
temperatures (oval shape, El1) of WT and NPY!/!
mice injected with either AAV-empty or AAV-NPY
into the Arc. Automatically extracted hottest/
coldest pixels and average temperature of area of
interest are displayed at the top left hand corner of
the images. Representative images of 8–10 mice
per group.
(B) Average maximum temperature of BAT (TBAT)
and average maximum temperature of lumbar
back (Tback) of WT and NPY
!/! mice injected with
either AAV-empty or AAV-NPY measured at week
2 after Arc injection. Data are means ± SEM. n = 8–
10 mice per group. *p < 0.05 versus genotype-
matched AAV-empty.
Arc NPY Controls Tyrosine
Hydroxylase Expression in the PVN
In order to determine other downstream
targets of Arc NPY signaling, we next
aimed to identify the chemical identity of
neurons activated by Arc-specific NPY.
Comparing the expression of mRNA
of various neurotransmitters in the PVN
of lean versus high-fat-diet-fed obese
a imals, which are known to have
elevated Arc NPY levels (Figures 1Aa
and 1Ac), we identified tyrosine hydroxy-
lase (TH), the rate-limiting enzyme in the
synthesis of catecholamines, a a major candidate on account
of its significant downregulation in expression in response to
a high-fat diet (Figure 4D). To confirm these PVN TH neurons
as t rg ts for Ar NPY signali g, we used our AAV-NPY expres-
sion system overexpr ssed or reintroduced NPY unilaterally
into Arc of WT and NPY!/!mice. As shown in Figure 4E and
quantified in Figure 4F, in both genotypes the elevated expres-
i n of NPY in the Arc caused a significant decrease in TH
mRNA expression in the PVN only on the injected side (at right
in the figure), but not on the contralateral noninjected control
side (left) or under conditions of empty virus injection. Impor-
tantly, another promin nt nucleus of TH expression, the locus
coeruleus (LC), also showed significant downregulation of TH
mRNA only on the injected side (at right on the figure) and not
on the contralateral noninjected control side at left or in empty
virus-injected controls (Figures 4E and 4F). Interestingly, the
downregula ion of TH mRNA in the two nuclei investigated
(PVN a d LC) was not significantly different between Arc-
sp cific NPY-overexpressing WT and NPY!/! mice (Figure 4F),
suggesting that extra-Arc NPY may not play a critical role in
the regulation of TH mRNA expression in the PVN or LC. Consis-
tent with the decreased mRNA level of TH in the PVN and LC of
Arc-specific NPY overexpressing mice, decreased TH protein
expression was also identified in these two nuclei by immunohis-
tochemistry (Figures 5A and 5B). In fact, in the PVN and LC of
ArcNPYmice, there were 61 ± 9 and 82 ± 8 TH-positive neurons,
respectively, in the injected side (at right in Figures 5A and 5B)
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overexpressing mice, decreased TH protein expression was also identified in these two nuclei 
by immunohistochemistry (Figures 5A and 5B). In fact, in the PVN and LC of ArcNPY mice, 
there were 61 ± 9 and 82 ± 8 TH-positive neurons, respectively, in the injected side (at right in 
Figures 5A and 5B) compared to 164 ± 7 and 138 ± 11 TH-positive neurons, respectively, on 
the contralateral noninjected control side (shown at left). This set of results clearly identifies 
TH-positive neurons in the PVN and LC as critical downstream targets of Arc NPY signaling 
and potential mediators of the associated reduction in energy expenditure.	  	  	  
	  	  	   	  compared to 164 ± 7 and 138 ± 11 TH-positive neurons, respec-tively, on the contralateral noninjected control side (shown atleft). This set of results clearly identifies TH-positive neurons in
the PVN and LC as critical downstream targets of Arc NPY
signaling and potential mediators of the associated reduction
in energy expenditure.
TH Expression in the PVN Is Controlled by Y1 Receptor
Signaling
Having established the role of Arc NPY signaling in the control of
TH expression in the PVN and LC, we next focused on identifying
the Y receptor(s) critical for mediating this action. To achieve
this, we initially used germline Y-receptor knockout models
Figure 4. Arc NPY Induced Signaling and Neurotransmitter Regulation
(A) Emulsion-dipped autoradiographs of POMCmRNA expression in the Arc of WT and NPY!/!mice unilaterally injected (on the right side of the figure) with AAV-
empty vectors and AAV-NPY vectors. The scale bar represents 40 mm. Images are representative of five to six mice per group. Arc, acuate nucleus; 3V, the third
cerebral ventricle.
(B and C) Quantification of GAD65 and AGRP mRNA expression in the Arc, respectively, expressed as a percent of expression level of AAV-empty-injected WT
mice. Data are means ± SEM. n = 5–6 mice per group. *p < 0.05 versus genotype-matched AAV-empty controls.
(D) In situ hybridization of TH mRNA in the PVN of WT mice fed with a chow diet or with a high-fat diet for 20 weeks. The scale bar represents 40 mm. Images are
representative of n = 5.
(E) Emulsion autoradiographs of TH mRNA expression determined by in situ hybridization in the PVN or locus coeruleus (LC) of WT and NPY!/!mice unilaterally
injected (right side) with either AVV-empty or AAV-NPY into the Arc. The scale bar represents 60 mm. 3V, the third cerebral ventricle; 4V, the fourth cerebral
ventricle; PVN, paraventricular nuclei.
(F) Quantification of THmRNA expression in the PVN and LC expressed as a percent of expression level of AAV-empty-injectedWTmice. Data are means ± SEM.
n = 5–6 mice per group. *p < 0.05 versus genotype-matched AAV-empty controls.
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TH Expression in the PVN Is Controlled by Y1 Receptor Signaling 
Having established the role of Arc NPY signaling in the control of TH expression in the PVN 
and LC, we next focused on identifying the Y receptor(s) critical for mediating this action. To 
achieve this, we initially used germline Y-receptor knockout models (Y1−/− and Y2−/− mice) 
and injected them unilaterally into the Arc with our AAV-NPY virus and using empty vector 
(AAV-empty) injection as a control. Compared to AAV-empty-injected WT and Y2−/− mice, TH 
mRNA levels analyzed by in situ hybridization were significantly decreased in the PVN and 
LC of AAV-NPY-injected WT and Y2−/− mice (Figures 5C and 5D). By contrast, TH mRNA 
(Y1!/! and Y2!/!mice) and injected themunilaterally into the Arc
with our AAV-NPY virus and using empty vector (AAV-
empty) injection as a control. Compa ed to AAV-empty-injected
WT and Y2!/! mic , TH mRNA levels analyzed by in situ
hybridization were significantly decreased in the PVN and
LC of AAV-NPY-injected WT and Y2!/! mice (Figures 5C and
5D). By contrast, TH mRNA expression in the PVN and LC
of AAV-NPY-injected Y1!/! mice did not differ from that of
Figure 5. Arc NPY Decreases TH Protein Expression through Y1 Receptor Signaling in TH Neurons of the PVN
(A and B) Immunohistochemistry of TH protein expression in the PVN (A; the scale bar represents 60 mm) and LC (B; scale bar = 100 mm) of NPY!/!mice 4 weeks
after unilateral injection (right side) of AVV-NPY into the Arc. (Ba) and (Bb) show the boxed areas in (B) at higher magnification (the scale bar represents 10 mm).
Images are representative of five mice per group. PVN, paraventricular hypothalamic nuclei; LC, locus coeruleus.
(C and D) Quantification of TH mRNA expression in the PVN and LC of WT, Y1!/!, and Y2!/!mice unilaterally injected into the Arc with AAV-empty or AAV-NPY
vectors. Data are means ± SEM. n = 5 mice per group. *p < 0.05 versus genotype-matched AAV-empty-injected control mice.
(E) Double labeling of in situ hybridization for Y1 mRNA and immunohistochemistry for TH expression in the PVN of WT mice. The scale bar represents 25 mm. A
higher magnification of the boxed area is shown in (Ea); the scale bar represents 5 mm. Black arrows indicate neurons positive only for TH and white arrows
neurons positive for both TH and Y1 receptors.
(F) Bright-field micrograph of reduced c-fos expression in unilateral deleted conditional Y1lox/lox mice (right side) followed by i.c.v delivery of [Leu31,Pro34] NPY
4 weeks later. The scale bar represents 40 mm.
(G) Emulsion-dipped autoradiographs of THmRNA expression in the PVN and the LC of unilaterally injected (right side) Y1lox/loxmicewith either AAV-empty vector
or AAV-Cre vector, followed by i.c.v. [Leu31,Pro34] NPY 4 weeks later. The scale bar represents 40 mm. Quantification of TH mRNA expression in the PVN and LC is
expressed as a percent of expression level of AAV-empty-injected Y1lox/lox control mice. 3V, the third cerebral ventricle; 4V, the fourth cerebral ventricle. Data are
means ± SEM. n = 4 mice per group. *p < 0.05 versus AAV-empty-injected control mice.
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expression in the PVN and LC of AAV-NPY-injected Y1−/− mice did not differ from that of 
AAV-empty-injected Y1−/− mice (Figures 5C and 5D). These results suggest that Y1 receptor 
signaling in TH neurons in the PVN can be directly activated by NPY derived from the Arc, 
mediating the inhibition of expression of TH mRNA. 
 To definitively prove that Y1 receptors in the PVN control TH expression, and to 
establish the sequence of activation of specific TH neuron populations in brain regions, we 
performed immunohistochemistry for TH combined with in situ hybridization for Y1 receptors. 
As shown in Figure 5E, a major proportion (68% ± 11%) of TH-immunoreactive neurons in the 
PVN were also positive for Y1 receptor expression, suggesting that activation of Y1 receptor 
signaling directly in these cells controls TH expression. To prove this functionally, we next 
injected conditional Y1 receptor knockout (Y1lox/lox) mice unilaterally into the PVN with a Cre-
recombinase-expressing AAV vector (AAV-Cre) in order to induce unilateral Y1 receptor 
deletion in this nucleus. Importantly, 4 weeks after Y1 receptor deletion, i.c.v. injection of the 
Y1 receptor-preferring agonist [Leu31,Pro34]NPY showed a significant reduction in c-fos activation 
only in the deleted site of the PVN compared to the nondeleted contralateral side ( Figure 5F, 
54 ± 7 c-fos-expressing nuclei in the Y1-receptor-deficient side at right in the figure versus 
101 ± 12 in the control side at left; data are means ± SEM of four mice per group, p = 0.005). 
Importantly, mice unilaterally depleted of Y1 receptors in the PVN, when i.c.v. injected 
4 weeks later with the Y1 receptor-preferring agonist [Leu31,Pro34]NPY, showed higher TH mRNA 
expression in the Y1 receptor depleted side of the PVN and LC (at right of each panel in 
Figure 5G) compared to the noninjected contralateral side of each nucleus (at left). By 
contrast, there was no difference between the injected and noninjected sides of the PVN and 
LC in brains of mice injected with the AAV-empty control vector (Figure 5G). The elevated 
PVN and LC TH mRNA expression seen in the Y1-deficient side of the brain also translated 
into an increase in TH protein levels in the corresponding side of the PVN and LC (Figures 6A 
and 6B). Importantly, this pattern of increased TH mRNA and protein expression on the side 
of the unilateral Y1 depletion in the PVN can also be seen in the nucleus of tractus solitarius 
(NTS) and in the C1/A1 adrenergic or noradrenergic neurons in the ventrolateral medulla 
(VLM) of the brainstem (Figure 6C), suggesting that NPY signaling on Y1 receptors in the 
PVN decreases catecholamine synthesis in this nucleus which subsequentially also triggers a 
reduction in TH production in the LC and other brainstem areas, potentially leading to 
decreased sympathetic outflow. 
 
Arc NPY Signaling Controls UCP1 Expression in BAT 
To further verify our hypothesis that increased Arc NPY-ergic tone can influence SNS activity, 
we chose to investigate the activity of BAT as it is known to be an intensely sympathetically 
innervated peripheral target tissue (Lever et al., 1988). First, we carried out bilateral surgical 
sympathetic denervation (Engel et al., 1992) of BAT to confirm the critical input from these 
neurons on this tissue and we measured the changes in protein levels of uncoupling protein 1 
(UCP1) in BAT as an indication of changes in activity. While baseline protein levels of UCP1 
were significantly increased in NPY−/− compared to WT mice, BAT denervation significantly 
reduced UCP1 levels in both genotypes (Figure 7A), confirming sympathetic activity as a 
major contributor to UCP1 protein expression. In addition, we also investigated the protein 
expression levels of peroxisome proliferator-activated receptor-γ coactivator (PGC1α), a key 
transcriptional regulator of UCP1 whose expression has been reported to be increased in 
response to activation of the sympathetic nervous system (Puigserver et al., 1998). 
Interestingly, PGC1α protein levels were not different among sham-operated and denervated 
groups of WT and NPY−/− mice (Figure 7B), suggesting little or no involvement of PGC1α in 
the Arc NPY induced sympathetically mediated regulation of BAT UCP1 expression. 
 Similar to the denervation experiment shown in Figure 7A, lack of NPY, as in 
NPY−/−+empty-injected mice, led to a strong increase in the UCP1 mRNA ( Figure 7C) and 
protein (Figure 7D) expression in the BAT compared to corresponding values in WT+empty 
mice, with quantification shown in Figure 7E. More importantly, Arc injection of NPY in either 
WT or NPY−/− mice markedly and significantly reduces UCP1 mRNA and protein expression 
in BAT (Figures 7C–7E). Indeed, there was a nearly 3-fold reduction in BAT UCP1 mRNA 
expression in ArcNPY relative to NPY−/−+empty mice, consistent with a direct effect of Arc 
NPY signaling on BAT function. Furthermore, we also investigated the expression of PGC1α 
in BAT in response to Arc NPY signaling. Similar to the denervation experiments, there was 
no significant difference in PGC1α protein level in the ArcNPY group compared to the other 
three groups ( Figure 7D, quantified in Figure 7F), albeit there was a trend to a reduction in 
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PGC1α protein expression in ArcNPY mice compared to NPY−/−+empty controls (p = 0.07), 
suggesting that reduction of UCP1 expression induced by elevated Arc NPY is not 
necessarily mediated by action of PGC1α in BAT. 
 
	  
 
 To further validate our hypothesis that the alterations of BAT activity were influenced 
by NPY signaling via Y1 receptors, we also injected germline Y1−/− mice with AAV-empty 
(Y1−/−+empty) or AAV-NPY (Y1−/−+NPY) into the Arc and investigated the expression of UCP1 
and PGC1α in BAT. At baseline, mice lacking the Y1 receptor, as in Y1−/−+empty mice, 
exhibited upregulated UCP1 protein levels compared to WT+empty mice ( Figure 7E). In 
contrast to the marked reduction in BAT UCP1 protein expression seen in WT+NPY and 
ArcNPY mice, Y1−/−+NPY mice showed no such decreases relative to Y1−/−+empty mice ( 
Figure 7E), and there was also no difference in the levels of PGC1α either (Figure 7E). These 
findings, together with our discovery of the effect of Y1 receptor deletion in the PVN on TH 
expression (Figures 5A and 5C), confirms that Y1 receptors in the brain, particularly in the 
PVN, are critical for the inhibitory action of Arc NPY on UCP1 expression in BAT.	  
control whole body energy homeostasis, as evidenced by a rapid
and robust reduction in energy expenditure in ArcNPY mice
well before body weight and adiposity were significantly
increased. The central mechanism behind this direct control of
energy expenditure initiated by Arc NPY is likely due to
decreased sympathetic nervous system activity, as shown by
decreased TH mRNA and protein expression in the PVN, LC,
and brai stem. Importantly, we identified Y1 receptors colocal-
ized on TH neurons in the PVN as the relay point, making it
unlikely that Arc NPY directly influences TH levels in the LC
and other regions in the brainstem. Consistent with a significant
decrease in activity of TH-expressing neurons in the brain, we
also demonstrated that this Arc-specific alteration of NPY
signaling led to a significant temperature reduction in BAT in
association with a downregulation of BAT UCP1 expression,
which could be reversed after surgical sympathetic denervation
to BAT. Therefore, these data show a causal relationship
between Arc NPY signaling and the sympathetic nervous system
activity. The pot ntial pathways, eurotransmitters and mecha-
nisms by which Arc NPY signaling may influence food intake,
BAT thermogenesis and energy expenditure are summarized in
Figure S2.
Figure 6. Y1 Receptors Signaling Controls TH Protein Levels in the PVN, LC, NTS, and A1/C1 Neurons
Immunohistochemistry of TH protein expression in the PVN (A), the LC (B), and the NTS (C) and A1/C1 region of Y1lox/lox mice unilaterally injected with AAV-Cre
(right side) followed by i.c.v injection of 1.5 ml [Leu31,Pro34] NPY 4weeks later. The scale bar represents 100 mm. Subpanels show higher magnifications of the boxed
areas; scale bars represent 40 mm. Images are representative of five mice. PVN, paraventricular nucleus; LC, locus coeruleus; NTS, nucleus of tractus solitarius;
C1/A1, adrenaline neurons/noradrenaline neurons; 3V, the third cerebral ventricle; 4V, the fourth cerebral ventricle; Cc, central canal.
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Discussion 
 
This study demonstrates that Arc NPY-induced signaling is critical for the control of the 
hypothalamic and brainstem TH systems that modulate sympathetic outflow, and 
subsequently energy expenditure including BAT thermogenesis. Results generated by our 
Arc-only NPY expression models suggest that while Arc NPY has an important role in 
stimulating feeding, most likely involving alterations in GAD65 and POMC activities in the 
hypothalamus, which will lead to obesity over time, the control of food intake is not the only 
critical function of Arc NPY. Indeed, we found that Arc-derived NPY could directly control 
whole body energy homeostasis, as evidenced by a rapid and robust reduction in energy 
expenditure in ArcNPY mice well before body weight and adiposity were significantly 
increased. The central mechanism behind this direct control of energy expenditure initiated by 
Arc NPY is likely due to decreased sympathetic nervous system activity, as shown by 
decreased TH mRNA and protein expression in the PVN, LC, and brainstem. Importantly, we 
identified Y1 receptors colocalized on TH neurons in the PVN as the relay point, making it 
unlikely that Arc NPY directly influences TH levels in the LC and other regions in the 
brainstem. Consistent with a significant decrease in activity of TH-expressing neurons in the 
brain, we also demonstrated that this Arc-specific alteration of NPY signaling led to a 
significant temperature reduction in BAT in association with a downregulation of BAT UCP1 
expression, which could be reversed after surgical sympathetic denervation to BAT. 
Therefore, these data show a causal relationship between Arc NPY signaling and the 
sympathetic nervous system activity. The potential pathways, neurotransmitters and 
mechanisms by which Arc NPY signaling may influence food intake, BAT thermogenesis and 
energy expenditure are summarized in Figure S2. 
 NPY-ergic tone in the Arc is increased during periods of energy deficiencies, and this 
is associated with the promotion of food consumption and conservation of energy. However, 
under the condition of oversupplied nutrition in high-caloric-diet-fed rodents or humans, 
elevated rather than decreased NPY levels mislead the brain and worsen the symptoms of 
the metabolic syndrome. In addition, elevation of Arc NPY expression during weight loss after 
energy restriction may be a strong factor in preventing further weight loss. In this study, 
experimental elevation of NPY in the Arc mimics these different conditions, allowing us to 
dissect the downstream neuronal circuits controlled by this altered Arc NPY signaling. 
NPY-ergic tone in the Arc is increased during periods of
energy deficiencies, and this is associated with the promotion
of food consumption and conservation of energy. However,
under the condition of oversupplied nutrition in high-caloric-
diet-fed rodents or humans, elevated rather than decreased
NPY levels mislead the brain and worsen the symptoms of the
metabolic syndrome. In addition, elevation of Arc NPY expres-
sion during we ght loss after energy restrictio may be a strong
factor in preventing further weight loss. In this study, exp i-
mental elevation of NPY in the Arc mimics these different condi-
tions, allowing us to dissect the downstream neuronal circuits
controlled by this altered Arc NPY signaling. Although Arc NPY
neurons project to several regions in the brain, the projection
to PVN TH-expressing neurons seems to be the most important
one for reducing sympathetic activity and thereby modulating
energy expenditure. Interestingly, our findings on Arc NPY
control of sympathetic output is consistent with a recent report
that chemical stimulation of the Arc in ra s altered cardiovascu ar
responses by modulating sympathetic nerve activity in the PVN
(Kawabe et al., 2012).
Our data show that the phenotypes related to BAT function in
WT+NPY and ArcNPY mice are very similar, suggesting that
extra-Arc NPYmay not be critical in altering sympathetic outflow
relevant to BAT activity. However, potential actions of extra-Arc
NPY, either in the brain or in the periphery, cannot be completely
ruled out. Indeed, a recent study in rats showed that virus- edi-
ated ov rexpr ssion of NPY in the DMH leads to body weight
gain associated with hyperphagia (Yang et al., 2009). Furth r-
more, it was also shown that knockdown of NPY in the DMH of
rats promotes the development of brown adipocytes in typical
WAT depots through sympathetic actions, and this increases
BAT activity and therefore enhances energy expenditure and
cold-induced thermogenesis (Chao et al., 2011). However, this
could be a rat-specific mechanism, since NPY expression in
the DMH of mice under normal conditions is rather low. In addi-
tion to the DMH, it has been shown that NPY can directly inhibit
eurons in the ventromedial nucleus (VMH), a crucial brain region
that suppresses food intake (King, 2006). I is als possible that
the lack of intact feedback circuits within the brain or from
peripheral tissues contributes to the differences in metabolic
effects of Arc NPY seen in WT and otherwise NPY-deficient
mice. In particular, the observed difference in body weight
between WT and NPY!/! mice after chronic overproduction of
NPY in the Arc highlights the importance of the entire NPY
system for achieving overall control of energy homeostasis.
The id ntification of TH-expressing neurons i the PVN, a crit-
ical brain region for the integration of neuroendocrine and auto-
nomic signals (Swanson and Sawchenko, 1980), as a major
target of Arc NPY action is a vital clue for understanding the
complex network of neurons regulating energy homeostasis.
Our data clearly demonstrate that Y1 receptor signaling in
TH-expressing neurons in the PVN suppresses the expression
of TH, and through this the activity of indices of sympathetic
nervous activity such as BAT temperature and BAT UCP1
expression. Located in the lateral parvoc llular ubregions of
the PVN, TH neurons are known to project to brainstem and
spi al cord auton mic r gulatory centers and to integrate sym-
pathetic/parasympathetic outflow (Swanson and Sawchenko,
Figure 7. Effects of Arc NPY Signaling on BAT UCP1 and PGC1a Expression
(A and B) Protein levels of UCP1 (A) and PGC1a (B) 3 weeks after bilateral sympathectomy of BAT of WT and NPY!/! mice. The sham-operated genotype-
matched mice were used as controls. Data are means ± SEM. n = 5–7 mice per group. *p < 0.05, **p < 0.01 versus genotype-matched controls or for the
comparison indicated by horizontal bar.
(C) UCP1mRNA expression levels in the BAT ofWT or NPY!/!mice 3 weeks after being injected into the Arc with either AAV-empty or AAV-NPY. The values were
expressed as a percent of expression level of WT+empty mice.
(D) UCP1 and PGC1a protein levels in the BAT of WT or NPY!/!mice 3 weeks after being injected into the Arc with either AAV-empty or AAV-NPY determined by
western blot. Images are representative of four to five mice per group. GAPDH is used as a loading control.
(E and F) quantification of UCP1 and PGC1a protein expression in the BAT 3 weeks after Arc injection of AAV-empty or AAV-NPY vectors into of WT, NPY!/!, and
Y1!/!mice, respectively. Data aremeans ± SEM. n = 5–7mice per group. *p < 0.05, **p < 0.01 versus genotype-matched controls or for the comparison indicated
by horizontal bar.
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Although Arc NPY neurons project to several regions in the brain, the projection to PVN TH-
expressing neurons seems to be the most important one for reducing sympathetic activity and 
thereby modulating energy expenditure. Interestingly, our findings on Arc NPY control of 
sympathetic output is consistent with a recent report that chemical stimulation of the Arc in 
rats altered cardiovascular responses by modulating sympathetic nerve activity in the PVN 
(Kawabe et al., 2012). 
 Our data show that the phenotypes related to BAT function in WT+NPY and ArcNPY 
mice are very similar, suggesting that extra-Arc NPY may not be critical in altering 
sympathetic outflow relevant to BAT activity. However, potential actions of extra-Arc NPY, 
either in the brain or in the periphery, cannot be completely ruled out. Indeed, a recent study 
in rats showed that virus-mediated overexpression of NPY in the DMH leads to body weight 
gain associated with hyperphagia ( Yang et al., 2009). Furthermore, it was also shown that 
knockdown of NPY in the DMH of rats promotes the development of brown adipocytes in 
typical WAT depots through sympathetic actions, and this increases BAT activity and 
therefore enhances energy expenditure and cold-induced thermogenesis (Chao et al., 2011). 
However, this could be a rat-specific mechanism, since NPY expression in the DMH of mice 
under normal conditions is rather low. In addition to the DMH, it has been shown that NPY 
can directly inhibit neurons in the ventromedial nucleus (VMH), a crucial brain region that 
suppresses food intake (King, 2006). It is also possible that the lack of intact feedback circuits 
within the brain or from peripheral tissues contributes to the differences in metabolic effects of 
Arc NPY seen in WT and otherwise NPY-deficient mice. In particular, the observed difference 
in body weight between WT and NPY−/− mice after chronic overproduction of NPY in the Arc 
highlights the importance of the entire NPY system for achieving overall control of energy 
homeostasis. 
 The identification of TH-expressing neurons in the PVN, a critical brain region for the 
integration of neuroendocrine and autonomic signals (Swanson and Sawchenko, 1980), as a 
major target of Arc NPY action is a vital clue for understanding the complex network of 
neurons regulating energy homeostasis. Our data clearly demonstrate that Y1 receptor 
signaling in TH-expressing neurons in the PVN suppresses the expression of TH, and 
through this the activity of indices of sympathetic nervous activity such as BAT temperature 
and BAT UCP1 expression. Located in the lateral parvocellular subregions of the PVN, TH 
neurons are known to project to brainstem and spinal cord autonomic regulatory centers and 
to integrate sympathetic/parasympathetic outflow (Swanson and Sawchenko, 1983). 
Furthermore, PVN anterograde tracing studies have demonstrated that the LC is a primary 
target of neuronal projections from the PVN (Reyes et al., 2005; Zheng et al., 1995). As the 
rate-limiting enzyme in the biosynthesis of the catecholamines dopamine, noradrenaline, and 
adrenaline, TH forms the primary control mechanism for the production of catecholamines. 
While PVN TH-positive neurons are most likely dopaminergic, the LC consists of a compact 
population of TH-positive neurons that are exclusively noradrenergic, readily identifiable by 
their expression of catecholamine-synthetic enzymes (Geerling et al., 2010). In addition, LC 
noradrenergic neurons project to a variety of other areas of the brain, including the 
hypothalamus, amygdala, hippocampus, and striatum, where they are involved in regulating 
stress responses and stress-related vigilance and arousal, not uncommon conditions 
associated with elevated Arc NPY levels mimicking negative energy balance. Importantly, it 
has also been shown that TH-positive neurons in the PVN directly project to brainstem 
autonomic regions such as the NTS and A1/C1 cell groups (Geerling et al., 2010). From 
there, the catecholamine-synthesizing neurons in the brainstem send efferent signals to the 
spinal cord and control many autonomic organs, including BAT, to regulate SNS-mediated 
thermogenesis and peripheral tissue metabolism. 
 Taken together, our data have demonstrated that increased NPY expression in the 
Arc as commonly seen under fasting, stress, or chronic-overfeeding conditions, acting via 
PVN Y1 receptors, results in a functional inhibition of TH tonus and BAT thermogenesis. Our 
results also show the inhibitory function of Arc NPY signaling in controlling POMC neurons, 
probably via altering GAD65 levels, and this likely contributes to increased food intake. 
Importantly, there was no change in AGRP expression upon Arc NPY administration, 
suggesting that there is no feedback regulation by NPY on AGRP neurons. This also 
suggests that AGRP, which is colocalized in some Arc NPY neurons, can act independently 
of NPY, allowing different components of energy homeostasis to be controlled by the same 
neurons. This new discovery of the pathways modifying neural sympathetic activity in 
response to Arc NPY provides greater insights into the hypothalamic regulation of energy 
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homeostasis. 
 
Experimental Procedures 
 
Animals 
All animal experiments were conducted in accordance with relevant guidelines and 
regulations. Male (wild-type, NPY−/−, Y1−/−, Y2−/−, conditional Y1 knockout Y1lox/lox, and 
NPYCre knockin) mice all on a mixed C57Bl6/129SVJ background were used for these 
experiments. They were housed under conditions of controlled temperature (22°C) with a 
12:12 hr light-dark cycle (lights on at 07:00 hr) and fed a standard chow diet with ad libitum 
access to water, except where noted. Generation of the NPY−/−, Y1−/−, Y2−/−, and conditional 
Y1lox/lox mice has been described previously (Howell et al., 2003; Karl et al., 2008; Sainsbury 
et al., 2002; Zhang et al., 2010). NPYCre knockin mice were generated as described in the 
Supplemental Experimental Procedures. 
 
Viral Vector Injection and Measurement of Body Weight and Fat Mass 
Hypothalamic Arc-targeted viral injection was performed as described in the Supplemental 
Experimental Procedures. The physiological efficacy of viral NPY expression was confirmed 
by the resultant increase in food intake. Body weight was monitored twice a week at the same 
time of the day for 3 weeks in the short-term experiment and weekly for the 8 week 
experiment. Whole-body fat was measured at 13 weeks of age with dedicated dual-energy X-
ray absorptiometry (DEXA; Lunar PIXImus2 mouse densitometer, GE Medical Systems, 
Madison, WI) as described previously (Shi et al., 2011). 
 
Indirect Calorimetry Studies, Food Intake, and Physical Activity 
Oxygen consumption rate (VO2) and carbon dioxide output (VCO2) were measured 1 week 
after AAV injection with an indirect calorimeter (Oxymax series; Columbus Instruments, 
Columbus, OH) as described previously (Shi et al., 2011). In brief, after 24 hr of 
acclimatization, VO2, VCO2, body weight, and daily food intake were measured over a 24 hr 
period, and the RER and energy expenditure were calculated. Relative physical activity of 
individually housed mice was also evaluated. 
 
BAT Temperature Measurements with Infrared Imaging 
Temperature of interscapular BAT (TBAT) and body temperature was measured by 
noninvasive high-sensitivity infrared camera (ThermoCAM T640, FLIR) as described in the 
Supplemental Experimental Procedures. Data were analyzed with the ThermaCAM 7 Pro 
software calculating the hottest pixel and average temperature of each area of interest. 
 
Intrascapular BAT Bilateral Sympathectomy 
Afferent sympathectomy of BAT was carried out in a subset of 11- to 12-week-old male mice 
immediately after they had been injected with AAV-empty or AAV-NPY virus as described in 
previously (Engel et al., 1992; Niijima et al., 1984). In brief, with a microscope, intrascapular 
BAT was exposed by cutting of the overlaying skin and the adjacent muscles. Five 
sympathetic nerve bundles supplying each lobe of BAT were identified, carefully lifted with 
forceps, and severed. A similar procedure was performed in sham-operated groups except 
without sympathetic nerve incision of BAT. The mice were placed on heat pads during 
surgery and until recovery. 
 
RNA Extraction and Quantitative Real-Time PCR 
BAT were dissected and immediately frozen in liquid N2, and total RNA was isolated with 
Trizol Reagent and processed for quantitative real-time PCR with the LightCycler system as 
described in the Supplemental Experimental Procedures. 
 
Western Blotting 
BAT samples from all groups were homogenized in RIPA buffer as previously described (Shi 
et al., 2011), and 20 µg protein was resolved by SDS-PAGE and immunoblotted with 
antibodies against UCP1 (Alpha Diagnostic International, San Antonio, TX), PGC1α 
(Calbiochem, Merck, Kilsyth, Australia), and GAPDH. Immunolabelled bands were quantified 
by densitometry. 
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In Situ Hybridization 
Coronal brain sections (20 µm) were cut on a cryostat and mounted on slides. Matching 
sections from the same coronal brain level from the four groups of mice (n = 5 mice/group) 
were assayed together using radiolabelled DNA oligonucleotides complementary to mouse 
POMC, GAD65, AGRP, NPY, and TH. Sequence of probes and details of the in situ 
hybridization methodology can be found in the Supplemental Experimental Procedures. 
 
Immunohistochemistry for Determination of NPY-Induced Changes in the Brain 
The mice were anaesthetized and the brains were perfused with saline and then 4% 
paraformaldehyde (PFA). Brains were postfixed in 4% PFA and then placed in 30% sucrose 
overnight and cut at 30 µm, and immunohistochemistry was performed as described in the 
Supplemental Experimental Procedures. After coverslipping, 12 sections from each mouse 
were visualized and counted for c-fos or TH immunoreactivity within the brain nuclei of 
interest with a Zeiss Axioplan light microscope. 
 
Double Immunostaining and In Situ Hybridization 
Five WT male mice were killed and brains were immediately removed and frozen. Coronal 
brain sections, 20 µm thick, were cut and mounted on slides. Double immunostaining assays 
were carried out as described in details in the Supplemental Experimental Procedures. 
 
Statistical Analysis 
All values are presented as means ± SEM. One- or two-way ANOVA (for body weight, basal 
food intake, VO2, VCO2, energy expenditure, physical activity, and RER) or repeated-
measures ANOVA (BAT and lumbar temperature) was used (GraphPad Prism 5, GraphPad 
Software). Bonferroni post hoc tests were performed to identify differences among means. p < 
0.05 was considered significant. 
 
Acknowledgments 
This work was supported by the National Health and Medical Research Council (NHMRC) of 
Australia with grant number 427661 and fellowships to S.L., A.S., P.B., and H.H. 
 
References 
Baranowska, B., Wolin_ska-Witort, E., Martyn_ska, L., Chmielowska, M., Mazurczak-Pluta, T., 
Boguradzka, A., and Baranowska-Bik, A. (2005). Sibutramine therapy in obese women—effects on 
plasma neuropeptide Y (NPY), insulin, leptin and beta-endorphin concentrations. Neuroendocrinol. Lett. 
26, 675–679.  
Batterham, R.L., Cowley, M.A., Small, C.J., Herzog, H., Cohen, M.A., Dakin, C.L., Wren, A.M., Brynes, 
A.E., Low, M.J., Ghatei, M.A., et al. (2002). Gut hormone PYY(3-36) physiologically inhibits food intake. 
Nature 418, 650–654.  
Bray, G.A., and York, D.A. (1998). The MONA LISA hypothesis in the time of leptin. Recent Prog. Horm. 
Res. 53, 95–117, discussion 117–118.  
Chao, P.T., Yang, L., Aja, S., Moran, T.H., and Bi, S. (2011). Knockdown of NPY expression in the 
dorsomedial hypothalamus promotes development of brown adipocytes and prevents diet-induced 
obesity. Cell Metab. 13, 573–583.  
Cowley, M.A., Smart, J.L., Rubinstein, M., Cerda ́ n, M.G., Diano, S., Horvath, T.L., Cone, R.D., and 
Low, M.J. (2001). Leptin activates anorexigenic POMC neurons through a neural network in the arcuate 
nucleus. Nature 411, 480–484.  
Egawa, M., Yoshimatsu, H., and Bray, G.A. (1991). Neuropeptide Y suppresses sympathetic activity to 
interscapular brown adipose tissue in rats. Am. J. Physiol. 260, R328–R334.  
Ellacott, K.L., and Cone, R.D. (2004). The central melanocortin system and the integration of short- and 
long-term regulators of energy homeostasis. Recent Prog. Horm. Res. 59, 395–408.  
Elmquist, J.K., Ahima, R.S., Elias, C.F., Flier, J.S., and Saper, C.B. (1998). Leptin activates distinct 
projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc. Natl. Acad. Sci. USA 95, 
741–746.  
Shi	  et	  al.:	  NPY	  and	  Energy	  Expenditure	  
Cell	  Metabolism,	  17(2):	  236-­‐248,	  2013	  
Engel, B.T., Sato, A., and Sato, Y. (1992). Responses of sympathetic nerves innervating blood vessels 
in interscapular, brown adipose tissue and skin during cold stimulation in anesthetized C57BL/6J mice. 
Jpn. J. Physiol. 42, 549–559.  
Geerling, J.C., Shin, J.W., Chimenti, P.C., and Loewy, A.D. (2010). Paraventricular hypothalamic 
nucleus: axonal projections to the brainstem. J. Comp. Neurol. 518, 1460–1499.  
Hahn, T.M., Breininger, J.F., Baskin, D.G., and Schwartz, M.W. (1998). Coexpression of Agrp and NPY 
in fasting-activated hypothalamic neurons. Nat. Neurosci. 1, 271–272.  
Horvath, T.L., Naftolin, F., and Leranth, C. (1992). GABAergic and catechol- aminergic innervation of 
mediobasal hypothalamic beta-endorphin cells projecting to the medial preoptic area. Neuroscience 51, 
391–399.  
Howell, O.W., Scharfman, H.E., Herzog, H., Sundstrom, L.E., Beck-Sickinger, A., and Gray, W.P. 
(2003). Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells. J. Neurochem. 
86, 646–659.  
Jegou, S., Blasquez, C., Delbende, C., Bunel, D.T., and Vaudry, H. (1993). Regulation of alpha-
melanocyte-stimulating hormone release from hypotha- lamic neurons. Ann. N Y Acad. Sci. 680, 260–
278.  
Kamegai, J., Tamura, H., Shimizu, T., Ishii, S., Sugihara, H., and Wakabayashi, I. (2000). Central effect 
of ghrelin, an endogenous growth hormone secreta- gogue, on hypothalamic peptide gene expression. 
Endocrinology 141, 4797– 4800.  
Karl, T., Duffy, L., and Herzog, H. (2008). Behavioural profile of a new mouse model for NPY deficiency. 
Eur. J. Neurosci. 28, 173–180.  
Kawabe, T., Kawabe, K., and Sapru, H.N. (2012). Cardiovascular responses to chemical stimulation of 
the hypothalamic arcuate nucleus in the rat: role of the hypothalamic paraventricular nucleus. PLoS 
ONE 7, e45180.  
King, B.M. (2006). The rise, fall, and resurrection of the ventromedial hypothal- amus in the regulation of 
feeding behavior and body weight. Physiol. Behav. 87, 221–244. 
 Lever, J.D., Mukherjee, S., Norman, D., Symons, D., and Jung, R.T. (1988). Neuropeptide and 
noradrenaline distributions in rat interscapular brown fat and in its intact and obstructed nerves of 
supply. J. Auton. Nerv. Syst. 25, 15–25.  
Lin, S., Storlien, L.H., and Huang, X.F. (2000). Leptin receptor, NPY, POMC mRNA expression in the 
diet-induced obese mouse brain. Brain Res. 875, 89–95.  
Lin, S., Boey, D., and Herzog, H. (2004). NPY and Y receptors: lessons from transgenic and knockout 
models. Neuropeptides 38, 189–200.  
Lin, E.J., Sainsbury, A., Lee, N.J., Boey, D., Couzens, M., Enriquez, R., Slack, K., Bland, R., During, 
M.J., and Herzog, H. (2006). Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic 
neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and 
obesity. Endocrinology 147, 5094–5101.  
Lundberg, J.M., Rudehill, A., and Sollevi, A. (1989). Pharmacological characterization of neuropeptide Y 
and noradrenaline mechanisms in sympathetic control of pig spleen. Eur. J. Pharmacol. 163, 103–113.  
Major, G.C., Doucet, E., Trayhurn, P., Astrup, A., and Tremblay, A. (2007). Clinical significance of 
adaptive thermogenesis. Int J Obes (Lond) 31, 204–212.  
Marks, J.L., Porte, D.J., Jr., Stahl, W.L., and Baskin, D.G. (1990). Localization of insulin receptor mRNA 
in rat brain by in situ hybridization. Endocrinology 127, 3234–3236.  
Milewicz, A., Mikulski, E., and Bidzin_ska, B. (2000). Plasma insulin, cholecystokinin, galanin, 
neuropeptide Y and leptin levels in obese women with and without type 2 diabetes mellitus. Int. J. Obes. 
Relat. Metab. Disord. 24(Suppl 2 ), S152–S153.  
Shi	  et	  al.:	  NPY	  and	  Energy	  Expenditure	  
Cell	  Metabolism,	  17(2):	  236-­‐248,	  2013	  	  
Mountjoy, K.G. (2010). Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes. 
Biochem. J. 428, 305–324. Nguyen, A.D., Mitchell, N.F., Lin, S., Macia, L., Yulyaningsih, E., Baldock, 
P.A., Enriquez, R.F., Zhang, L., Shi, Y.C., Zolotukhin, S., et al. (2012). Y1 and Y5 receptors are both 
required for the regulation of food intake and energy homeostasis in mice. PLoS ONE 7, e40191.  
Niijima, A., Rohner-Jeanrenaud, F., and Jeanrenaud, B. (1984). Role of ventro- medial hypothalamus on 
sympathetic efferents of brown adipose tissue. Am. J. Physiol. 247, R650–R654. 
 Ollmann, M.M., Wilson, B.D., Yang, Y.K., Kerns, J.A., Chen, Y., Gantz, I., and Barsh, G.S. (1997). 
Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278, 
135–138.  
Puigserver, P., Wu, Z., Park, C.W., Graves, R., Wright, M., and Spiegelman, B.M. (1998). A cold-
inducible coactivator of nuclear receptors linked to adap- tive thermogenesis. Cell 92, 829–839.  
Reyes, B.A., Valentino, R.J., Xu, G., and Van Bockstaele, E.J. (2005). Hypothalamic projections to locus 
coeruleus neurons in rat brain. Eur. J. Neurosci. 22, 93–106.  
Rosen, E.D., and Spiegelman, B.M. (2006). Adipocytes as regulators of energy balance and glucose 
homeostasis. Nature 444, 847–853.  
Sainsbury, A., and Zhang, L. (2010). Role of the arcuate nucleus of the hypo- thalamus in regulation of 
body weight during energy deficit. Mol. Cell. Endocrinol. 316, 109–119. 
Sainsbury, A., Cusin, I., Rohner-Jeanrenaud, F., and Jeanrenaud, B. (1997a). Adrenalectomy prevents 
the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats. Diabetes 46, 
209–214.  
Sainsbury, A., Rohner-Jeanrenaud, F., Cusin, I., Zakrzewska, K.E., Halban, P.A., Gaillard, R.C., and 
Jeanrenaud, B. (1997b). Chronic central neuropeptide Y infusion in normal rats: status of the 
hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia. Diabetologia 40, 1269–
1277.  
Sainsbury, A., Schwarzer, C., Couzens, M., Fetissov, S., Furtinger, S., Jenkins, A., Cox, H.M., Sperk, 
G., Ho ̈ kfelt, T., and Herzog, H. (2002). Important role of hypothalamic Y2 receptors in body weight 
regulation revealed in conditional knockout mice. Proc. Natl. Acad. Sci. USA 99, 8938–8943.  
Shi, Y.C., Lin, S., Castillo, L., Aljanova, A., Enriquez, R.F., Nguyen, A.D., Baldock, P.A., Zhang, L., 
Bijker, M.S., Macia, L., et al. (2011). Peripheral- specific y2 receptor knockdown protects mice from 
high-fat diet-induced obesity. Obesity (Silver Spring) 19, 2137–2148.  
Stephens, M., Ludgate, M., and Rees, D.A. (2011). Brown fat and obesity: the next big thing? Clin. 
Endocrinol. (Oxf.) 74, 661–670. Swanson, L.W., and Sawchenko, P.E. (1980). Paraventricular nucleus: 
a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 31, 410–
417.  
Swanson, L.W., and Sawchenko, P.E. (1983). Hypothalamic integration: orga- nization of the 
paraventricular and supraoptic nuclei. Annu. Rev. Neurosci. 6, 269–324.  
Tolle, V., and Low, M.J. (2008). In vivo evidence for inverse agonism of Agouti-related peptide in the 
central nervous system of proopiomelanocor- tin-deficient mice. Diabetes 57, 86–94.  
Vergoni, A.V., and Bertolini, A. (2000). Role of melanocortins in the central control of feeding. Eur J 
Pharmacol. 405, 25–32.  
Virtanen, K.A., Lidell, M.E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., 
Savisto, N.J., Enerba ̈ck, S., and Nuutila, P. (2009). Functional brown adipose tissue in healthy adults. 
N. Engl. J. Med. 360, 1518–1525.  
Whittle, A.J., Lo ́ pez, M., and Vidal-Puig, A. (2011). Using brown adipose tissue to treat obesity - the 
central issue. Trends Mol. Med. 17, 405–411. 
 Yang, L., Scott, K.A., Hyun, J., Tamashiro, K.L., Tray, N., Moran, T.H., and Bi, S. (2009). Role of 
dorsomedial hypothalamic neuropeptide Y in modulating food intake and energy balance. J. Neurosci. 
Shi	  et	  al.:	  NPY	  and	  Energy	  Expenditure	  
Cell	  Metabolism,	  17(2):	  236-­‐248,	  2013	  
29, 179–190.  
Zarjevski, N., Cusin, I., Vettor, R., Rohner-Jeanrenaud, F., and Jeanrenaud, B. (1993). Chronic 
intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic 
changes of obesity. Endocrinology 133, 1753–1758.  
Zhang, L., Macia, L., Turner, N., Enriquez, R.F., Riepler, S.J., Nguyen, A.D., Lin, S., Lee, N.J., Shi, Y.C., 
Yulyaningsih, E., et al. (2010). Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat 
accretion. Int J Obes (Lond) 34, 357–373.  
Zheng, J.Q., Seki, M., Hayakawa, T., Ito, H., and Zyo, K. (1995). Descending projections from the 
paraventricular hypothalamic nucleus to the spinal cord: anterograde tracing study in the rat. Okajimas 
Folia Anat. Jpn. 72, 119–135.  
 
	  
